Search

Your search keyword '"Lattante S"' showing total 208 results

Search Constraints

Start Over You searched for: Author "Lattante S" Remove constraint Author: "Lattante S"
208 results on '"Lattante S"'

Search Results

1. Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene

2. Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene

3. Generation of induced pluripotent stem cells (CSSi017-A)(12862) from a patient carrying a repeat expansion in the C9orf72 gene and with amyotrophic lateral sclerosis

4. Analysis of STMN2 CA repeats in italian ALS patients shows no association

6. Generation of an induced pluripotent stem cell line (UCSCi001-A) from a patient with early-onset amyotrophic lateral sclerosis carrying a FUS variant

7. Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein

8. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

9. Adult phenotype in Koolen-de Vries/KANSL1 haploinsufficiency syndrome

10. Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients

11. Generation of an induced pluripotent stem cell line (UCSCi002-A) from a patient with a variant in TARDBP gene associated with familial amyotrophic lateral sclerosis and frontotemporal dementia

12. Allele-specific silencing as therapy for familial amyotrophic lateral sclerosis caused by the p.G376D TARDBP mutation

13. Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients

14. FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees

17. Clinical Heterogeneity of ALS-Implications for Models and Therapeutic Development

18. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

19. Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein

20. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

21. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

22. High-throughput genetic testing in ALS: The challenging path of variant classification considering the acmg guidelines

24. Optical properties of N-succinimidyl bithiophene and the effects of the binding to biomolecules: Comparison between coupled-cluster and time-dependent density functional theory calculations and experiments

28. The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis

29. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

30. Germline pathogenic variant in PIK3CA leading to symmetrical overgrowth with marked macrocephaly and mild global developmental delay

31. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

32. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

33. Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene.

34. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

35. HFE p.H63D polymorphism does not influence ALS phenotype and survival

36. Genetic counselling in ALS: facts, uncertainties and clinical suggestions

37. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

38. Interplay between stimulated emission and singlet-singlet annihilation in oligothiophene dioxide thin films.

39. The role of excitons’ quasiequilibrium in the temperature dependence of the poly(9,9-dioctylfluorene) β phase photoluminescence.

41. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

42. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients

43. Nonradiative relaxation in thiophene-S,S-dioxide derivatives: The role of the environment

44. ATXN2 polyQ intermediate repeats are a modifier of ALS survival

45. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

46. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

47. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

48. Erratum: Optical properties of N-succinimidyl bithiophene and the effects of the binding to biomolecules: Comparison between coupled-cluster and time-dependent density functional theory calculations and experiments (Journal Physical Chemistry B (2006) 110B (18651))

49. TBK1 is associated with ALS and ALS-FTD in Sardinian patients

50. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry

Catalog

Books, media, physical & digital resources